Galectin Therapeutics (GALT) Preferred Stock Liabilities (2011 - 2026)
Galectin Therapeutics' Preferred Stock Liabilities was $1.72 million in Q2 2026, unchanged from $1.72 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Preferred Stock Liabilities (2011 - 2026) Analysis & Trends
From Q4 2011 onward, Galectin Therapeutics has reported Preferred Stock Liabilities for 55 quarters.
- Preferred Stock Liabilities shows a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- In earlier years, Preferred Stock Liabilities was $1.72 million in FY2024 (unchanged), $1.72 million in FY2023 (unchanged), $1.72 million in FY2022 (unchanged) and $1.72 million in FY2021 (unchanged).
- Per Business Quant data, GALT's Preferred Stock Liabilities in the three quarters before Q2 2026 was $1.72 million (Q1 2026), $1.72 million (Q4 2025) and $1.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Galectin Therapeutics | 257.29 Mn | 257.29 Mn | - | 1.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.72 Mn |
| Mar 31, 2026 | 1.72 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Dec 31, 2024 | 1.72 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.72 Mn |
| Dec 31, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 1.72 Mn |
| Dec 31, 2022 | 1.72 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 1.72 Mn |
| Mar 31, 2022 | 1.72 Mn |
| Dec 31, 2021 | 1.72 Mn |
| Sep 30, 2021 | 1.72 Mn |
API Access
Galectin Therapeutics Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();